Zhendong Zheng

Subtype-specific ZMYND10 expression as a potential novel prognostic and treatment marker for ER-positive/HER2-negative breast cancer

Abstract Breast cancer (BC) is a heterogeneous malignant tumor that currently lacks reliable biomarkers. Identifying such biomarkers would enable better risk stratification and present potential treatment options for estrogen receptor positive/human epidermal growth factor recept...